July 15, 2019
This morning Teva Pharmaceutical Industries announced that the FDA greenlighted its AirDuo Digihaler, a sensor-enabled inhaler. The product, classified as a maintenance asthma inhaler, has a built-in sensor that sends usage data to a corresponding app on a user's smartphone. This information can also be sent to the user’s provider.
The sensor technology is also able to monitor inspiratory flow...
July 15, 2019
Gone are the days of endless finger pricks to test blood glucose levels and complicated mental calculations to deduce carbohydrate ratios with insulin. The growth of people with diabetes by 314 million in the last 34 years has created an ever-expanding market in diabetes management products.
Consumers are now inundated with new technology streamlining lives with less needles and more real-time...
Omada CEO Sean Duffy. Photo credit: Omada
July 11, 2019
Omada Health, the digital health company that recently raised $73 million, came on to the digital health scene in 2011 with a focus on diabetes and chronic conditions. As the company continues to carve out its legacy in the digital health world, it is taking a cue from a more established industry.
“We’re one of the most life sciences-like digital health companies. We don’t fit perfectly into any...
July 9, 2019
Cloud-based computing could offer major benefits to pharmaceutical companies in the area of drug development as they grapple with rising costs and avalanches of data that need to be collected, analyzed and shared.
In particular, the technology could help streamline operations and develop business cases as to whether a drug is likely to be needed — or financially viable.
“If you’ve got big pots of...
July 8, 2019
Pharmaceutical company UCB and DEARhealth, a disease management software company, are joining forces on a new initiative aimed at predicting health outcomes for patients with epilepsy. The pair will use DEARhealth’s platform, which integrates artificial intelligence with EHRs.
“This technology will ensure that specific subpopulations within epilepsy will all receive the specific care needed for...
July 3, 2019
Cloud technology opens up the potential for exciting innovations when it comes to the design and execution of clinical trials, but data security and privacy concerns are holding innovation at a snail’s pace.
Despite these misgivings, cloud-based solutions could in fact offer greater security, as well as the ability to access large pools of data that would improve an organization’s ability to...